Implanet SA (IMPZY)
0.08
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Implanet Debt to Equity Ratio: -31.75 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | -31.75 |
| June 30, 2023 | 1.072 |
| December 31, 2022 | 1.691 |
| June 30, 2022 | 2.922 |
| December 31, 2021 | 3.048 |
| June 30, 2021 | 9.842 |
| December 31, 2020 | 4.041 |
| June 30, 2020 | 3.172 |
| December 31, 2019 | 2.359 |
| June 30, 2019 | 1.546 |
| December 31, 2018 | 1.082 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.6006 |
| December 31, 2017 | 0.3443 |
| June 30, 2017 | 0.5086 |
| December 31, 2016 | 0.3441 |
| June 30, 2016 | 0.4907 |
| December 31, 2015 | 0.3085 |
| June 30, 2015 | 0.2528 |
| December 31, 2014 | 0.4705 |
| June 30, 2014 | 0.4028 |
| December 31, 2013 | 0.3982 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-31.75
Minimum
Dec 2023
9.842
Maximum
Jun 2021
-0.206
Average
2.641
Median
Debt to Equity Ratio Benchmarks
| DBV Technologies SA | -- |
| Cellectis SA | 0.3968 |
| PHAXIAM Therapeutics SA (DELISTED) | -- |
| Genfit SA | 0.9462 |
| Innate Pharma SA | 0.7525 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 11.76M |
| Total Liabilities (Quarterly) | 11.95M |
| Shareholders Equity (Quarterly) | -0.1923M |
| Current Ratio | 0.7148 |
| Net Debt Paydown Yield | 0.79% |